ProteoMediX Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $74.1M

ProteoMediX General Information

Description

Developer of diagnostic biomarkers designed to assist in early detection and define the cancer stage. The company's biomarkers offer discrimination of aggressive and indolent cancers with better accuracy than available clinical standards, enabling physicians to treat their patients in an enhanced way.

Contact Information

Website
www.proteomedix.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Wagistrasse 23
  • 8952 Schlieren
  • Switzerland
+41 044
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Biotechnology
Parent Company
Onconetix
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Wagistrasse 23
  • 8952 Schlieren
  • Switzerland
+41 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProteoMediX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 15-Dec-2023 $74.1M Completed Generating Revenue
8. Later Stage VC 21-Sep-2021 Completed Generating Revenue
7. Later Stage VC (Series B) 10-Aug-2018 Completed Generating Revenue
6. Later Stage VC 16-Aug-2016 Completed Generating Revenue
5. Later Stage VC (Series B) 30-Jan-2015 Completed Generating Revenue
4. Early Stage VC (Series A) 12-Jan-2012 Completed Generating Revenue
3. Grant 03-Mar-2010 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2010 Completed Startup
1. Grant 30-Sep-2009 $19.2K Completed Startup
To view ProteoMediX’s complete valuation and funding history, request access »

ProteoMediX Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
Preference
Preference 84,200 $1.004673 $50.23 $50.23 1x $50.23 20.41%
Preference 65,000 $1.004673 $40.19 $40.19 1x $40.19 15.75%
To view ProteoMediX’s complete cap table history, request access »

ProteoMediX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diagnostic biomarkers designed to assist in early detection and define the cancer stage. The company's biom
Diagnostic Equipment
Schlieren, Switzerland
10 As of 2024

Siena, Italy
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ProteoMediX Competitors (36)

One of ProteoMediX’s 36 competitors is Exosomics, a Venture Capital-Backed company based in Siena, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exosomics Venture Capital-Backed Siena, Italy
Foundation Medicine Formerly VC-backed Boston, MA
Cellmade Private Equity-Backed Ruffieux, France
Agendia Venture Capital-Backed Irvine, CA
Akonni Biosystems Venture Capital-Backed Frederick, MD
You’re viewing 5 of 36 competitors. Get the full list »

ProteoMediX Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

ProteoMediX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240288433-A1 Combined method of detecting proteins in human samples and mpmri data Pending 29-Jun-2021
WO-2023274741-A1 Combined method of detecting proteins in human samples and mpmri data Inactive 29-Jun-2021
EP-4363852-A1 Method of detecting proteins in human samples and uses of such methods Pending 29-Jun-2021
US-20240337659-A1 Method of detecting proteins in human samples and uses of such methods Pending 29-Jun-2021
WO-2023274742-A1 Method of detecting proteins in human samples and uses of such methods Inactive 29-Jun-2021 G01N33/57555
To view ProteoMediX’s complete patent history, request access »

ProteoMediX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProteoMediX Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altos Venture Venture Capital Minority
BioBac Angel Group Minority
New Horizon Health Corporation Minority
Startup Invest Venture Capital Minority
Venture (Switzerland) Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

ProteoMediX FAQs

  • Where is ProteoMediX headquartered?

    ProteoMediX is headquartered in Schlieren, Switzerland.

  • What is the size of ProteoMediX?

    ProteoMediX has 10 total employees.

  • What industry is ProteoMediX in?

    ProteoMediX’s primary industry is Diagnostic Equipment.

  • Is ProteoMediX a private or public company?

    ProteoMediX is a Private company.

  • What is the current valuation of ProteoMediX?

    The current valuation of ProteoMediX is .

  • What is ProteoMediX’s current revenue?

    The current revenue for ProteoMediX is .

  • How much funding has ProteoMediX raised over time?

    ProteoMediX has raised $20.8M.

  • Who are ProteoMediX’s investors?

    Altos Venture, BioBac, New Horizon Health, Startup Invest, and Venture (Switzerland) are 5 of 7 investors who have invested in ProteoMediX.

  • Who are ProteoMediX’s competitors?

    Exosomics, Foundation Medicine, Cellmade, Agendia, and Akonni Biosystems are some of the 36 competitors of ProteoMediX.

  • When was ProteoMediX acquired?

    ProteoMediX was acquired on 15-Dec-2023.

  • Who acquired ProteoMediX?

    ProteoMediX was acquired by Onconetix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process